Recruiting

Observational Study

Sponsor:

Tirgan, Michael H., M.D.

Code:

NCT01423981

Conditions

Keloid

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

This trial intends to gather very basic clinical information about keloid, its patterns of presentation, family history, ethnic background and correlation with the type of keloid, as well as prior treatment results that patients have had received.

Conditions

Keloid

Study ID

NCT01423981

Start date

Nov, 2011

Status verified date

Oct, 2016

Completion date

Jun, 2031

Anticipated

Primary completion date

Dec, 2030

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

1. Patients must have clinically confirmed diagnosis of keloid
2. Adults, age over 18
3. Parent or legal guardian may participate if patient is under the age of 18
4. Able and willing to complete a web based survey

Exclusion Criteria:

  • No one will be excluded from this study as long as the inclusion criteria are met.

Study Design

Enrollment

10000 participants

Anticipated

Interventions and Outcome Measures

Arms

Patients with keloid disorder.

All participants have a clinical diagnosis of keloid.

Primary outcome measure

  • Determine the prevalence different phenotypes of keloid in participants. [ Time Frame: Two years ]

Central Contacts and Locations

Central contacts

Locations

Michael H. Tirgan, MD

Recruiting

New York, New York, United States, 10023

Contacts

Michael H Tirgan, MD

212-874-4200htirgan@gmail.com

Principal Investigator:

Michael H Tirgan, MD

More Information

Sponsor

Tirgan, Michael H., M.D.

Last update posted

Oct 4, 2016

Last verified

Oct, 2016

Keywords

  • Keloid
  • Scar
  • hypertrophic scar
  • familial keloid

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Tirgan, Michael H., M.D. on 2016-10-04.